Anthony R. Gangloff - Concepedia

Author

Anthony R. Gangloff

Takeda (United States)

Also Known As

A. R. GANGLOFF, A. R. Gangloff, ANTHONY R. GANGLOFF, Anthony Gangloff, Anthony R Gangloff, Anthony R. Gangloff

Publications

755

Citations

H-Index

Concepts

All Affiliations

Takeda (United States)Sunesis (United States)University of Notre Dame

About

Anthony R. Gangloff is an author at Takeda (United States) specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	287
2	Natural Sciences	8	8	568
3	Allergy	4	4	91
4	Biochemistry	4	4	136
5	Engineering	2	2	142

Anthony R. Gangloff

Publications

752

Citations

H-Index

Page 1

	Year	Citations
Exploration of the HDAC2 foot pocket: Synthesis and SAR of substituted N-(2-aminophenyl)benzamides Jerome C. Bressi, Andy Jennings, R.J. Skene, Bioorganic & Medicinal Chemistry Letters Combinatorial ChemistryMedicinal ChemistryNatural SciencesOrganic ChemistryHdac2 Foot Pocket	2010	249
Synthesis of 3,5-disubstituted-1,2,4-oxadiazoles using tetrabutylammonium fluoride as a mild and efficient catalyst Anthony R. Gangloff, Joane Litvak, Emma Shelton, Tetrahedron Letters Chemical EngineeringEngineeringNatural SciencesTetrabutylammonium FluorideDiversity-oriented Synthesis	2001	120
Benzimidazole and imidazole inhibitors of histone deacetylases: Synthesis and biological activity Jerome C. Bressi, Ron de Jong, Yiqin Wu, Bioorganic & Medicinal Chemistry Letters Biological ActivityHistone DeacetylasesMedicinal ChemistryPharmaceutical ChemistryBiochemistry	2010	53
Rhodium-catalyzed heterocycloaddition route to 1,3-oxazoles as building blocks in natural products synthesis Richard D. Connell, Mark J. Tebbe, Anthony R. Gangloff, Tetrahedron	1993	47
Highly potent non-peptidic inhibitors of the HCV NS3/NS4A serine protease David Sperandio, Anthony R. Gangloff, Joane Litvak, Bioorganic & Medicinal Chemistry Letters Protease InhibitorsBiochemistryMedicineAntiviral Drug DevelopmentAntiviral Therapy	2002	40
Generation and use of a zinc derivative of a functionalized 1,3-oxazole. Solution of the virginiamycin/madumycin oxazole problem Anthony R. Gangloff, Bjoern Aakermark, Paul Helquist The Journal of Organic Chemistry Virginiamycin/madumycin Oxazole ProblemBioorganic ChemistryAltmetric Attention ScoreOrganic ChemistryChemistry	1992	40
Dibasic inhibitors of human mast cell tryptase. Part 2: Structure–activity relationships and requirements for potent activity Kenneth D. Rice, Vivian R. Wang, Anthony R. Gangloff, Bioorganic & Medicinal Chemistry Letters AllergyMedicineMast Cell DisorderDibasic InhibitorsMechanism Of Action	2000	37
Discovery of novel benzo[b][1,4]oxazin-3(4H)-ones as poly(ADP-ribose)polymerase inhibitors Anthony R. Gangloff, Jason W. Brown, Ron de Jong, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryMedicineNatural SciencesRational Drug DesignPolymerase Inhibitors	2013	34
Dibasic inhibitors of human mast cell tryptase. Part 1: Synthesis and optimization of a novel class of inhibitors Kenneth D. Rice, Anthony R. Gangloff, Elaine Y. Kuo, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryAllergyMedicineNatural SciencesMast Cell Disorder	2000	29
Synthesis of the oxazole- and diene-containing C9–C23 fragment of the type a streptogramin antibiotics Mikael Bergdahl, Robert Hett, Timothy L. Friebe, Tetrahedron Letters Right-hand PortionMedicinal ChemistryDiversity Oriented SynthesisBioorganic ChemistryBiochemistry	1993	29

Page 1